
A Hollywood drug scandal threatens to expose the dark underbelly of celebrity culture, as the “Ketamine Queen” prepares to plead guilty.
Story Highlights
- Jasveen Sangha, known as the “Ketamine Queen,” will plead guilty to supplying Matthew Perry with the fatal ketamine dose.
- Sangha is the last of five defendants in the case, highlighting a complex network of celebrity drug suppliers.
- The case draws attention to the risks of unsupervised ketamine use for depression.
- Implications may include policy changes and increased scrutiny on celebrity drug use.
Celebrity Drug Scandal Unveiled
Jasveen Sangha, dubbed the “Ketamine Queen,” is set to plead guilty in a case that has rocked Hollywood. Sangha’s role in supplying Matthew Perry with a fatal ketamine dose highlights a sophisticated network catering to celebrities seeking drugs. The case has captured public attention, reminding us of the risks faced by high-profile individuals in search of relief from mental health struggles.
Matthew Perry, the beloved actor, struggled with depression and sought ketamine therapy. Legal access was limited by his doctor, prompting Perry to obtain the drug through illegal channels, facilitated by assistants and friends. Sangha became Perry’s primary source, orchestrating the supply chain that ultimately led to his tragic overdose.
#BREAKING ‘Ketamine Queen’ pleads guilty to selling fatal dose to Matthew Perry https://t.co/M2QSjXNWz5
— WGN TV News (@WGNNews) September 3, 2025
Legal Ramifications and Investigation
Federal prosecutors have worked meticulously to dismantle the underground operation that supplied Perry. Sangha is among five defendants in the case, with her guilty plea marking the conclusion of the investigation. This high-profile trial underscores the vulnerabilities in celebrity circles, where access to dangerous substances is alarmingly easy.
The legal proceedings have spotlighted the need for more stringent regulations on drugs like ketamine, especially concerning their off-label use for mental health treatment. The case echoes past Hollywood tragedies, reminding us that celebrity status does not shield individuals from the dangers of addiction.
Implications for Mental Health and Drug Policy
The fallout from this case is expected to reverberate through Hollywood and beyond. In the short term, Perry’s family and fans may find closure, while the public gains a deeper understanding of the risks associated with unsupervised drug use. Long-term effects could include policy changes regarding ketamine prescriptions and increased monitoring of celebrity medical treatments.
As we await Sangha’s formal guilty plea, the case serves as a stark reminder of the complexities surrounding mental health treatment and the responsibilities of those who enable destructive behaviors. The revelations from this case could prompt significant shifts in how we address addiction and drug abuse in high-profile communities.
Sources:
Matthew Perry and the Hollywood Drug Network Exposed by His Death
Jasveen Sangha, Known as ‘Ketamine Queen,’ Accused of Selling Matthew Perry Fatal Dose
‘Ketamine Queen’ Accused of Selling Fatal Dose to Matthew Perry



























